Breast Organotypic Cancer Models.

Area of Science:

• Oncology
• Biomedical Engineering
• Cell Biology

Background:

• Breast cancer is a leading global health concern, with millions of new cases and deaths annually.
• Current research predominantly uses 2D cell cultures and animal models, which have limitations in predicting human outcomes.
• Ethical concerns and cost-effectiveness issues also challenge the reliance on animal models in preclinical cancer research.

Purpose of the Study:

• To highlight the limitations of traditional 2D cell cultures and animal models in breast cancer research.
• To introduce organotypic cultures as advanced 3D models that better mimic the in vivo microenvironment.
• To emphasize the potential of organotypic cultures as alternatives for preclinical studies and human risk assessment.

Main Methods:

• Exploration of organotypic culture techniques for breast cancer research.
• Description of multicellular spheroids, organoids, 3D bioreactors, and tumor slices as key organotypic models.
• Focus on maintaining a three-dimensional (3D) microenvironment crucial for studying cancer behavior.

Main Results:

• Organotypic cultures demonstrate superior mimicry of in vivo tissue architecture compared to 2D models.
• These 3D models offer a more relevant platform for understanding breast cancer progression and response to therapies.
• The use of organotypic cultures can potentially reduce the number of animal experiments required.

Conclusions:

• Organotypic cultures represent a significant advancement in breast cancer research methodologies.
• They serve as valuable tools for improving the predictivity of preclinical studies and human risk assessment.
• The adoption of these 3D models is crucial for overcoming the limitations of conventional research approaches.